Menu
Not yet recruiting NCT07676136

A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients

No phase Interventional Disorders of Gut-brain Interaction Inflammatory Bowel Disease (IBD) Irritable Bowel Syndrome Abdominal Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Gut directed hypnotherapy via telephone intervention, Educational recording.
Who it may be relevant to
Registry conditions: Disorders of Gut-brain Interaction, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome, Abdominal Pain. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and/or nausea will be considered for enrollment.

Interventions

  • Behavioral Gut directed hypnotherapy via telephone intervention
    Participants will undergo a self-directed gut-directed hypnosis intervention over the telephone.
  • Behavioral Educational recording
    Participants will listen to educational material over the telephone about their gastrointestinal symptoms.

Primary outcome measures

  • Recruitment rate [Time frame: Up to 1 year.]
  • Number of participants who adhered to intervention [Time frame: 3 months.]
  • Retention rate [Time frame: 3 months.]

Eligibility criteria

Inclusion criteria

  • Adults admitted to the GI inpatient service with expected length of stay >24 hours
  • Prior diagnosis of a disorder of gut-brain interaction, esophageal disorder, or inflammatory bowel disease
  • Reason for hospitalization related to symptom management for exacerbation of visceral pain and/or nausea.

Exclusion criteria

  • Currently using hypnosis
  • severe developmental delay or cognitive impairment
  • serious mental illness (i.e. psychosis or dissociation)
  • hearing impairment
  • Non-English speaking
  • enrolled in another trial for GI symptom management
  • admitted for GI procedure

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • Stanford University — Stanford

Identifiers

NCT: NCT07676136 · 83851

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗